14. LOSS PER SHARE

The Company incurred a net loss for the three months ended January 31, 2015, therefore potentially dilutive securities were not included in basic and diluted shares outstanding due to their antidilutive effect.

Options, warrants, restricted shares and shares issuable upon conversion of preferred shares to acquire 2,215,968 and 717,105 shares of common stock were not included in the weighted average shares outstanding calculation of diluted loss per common share for the three months ended January 31, 2015 and 2014, respectively, as the effect of their inclusion would be anti-dilutive.

The table below provides shares issuable under potentially dilutive securities that were not included in EPS due to their dilutive effect: total potentially dilutive shares outstanding, including those that are anti-dilutive, at January 31, 2015:

Shares issuable upon conversion of preferred stock		1,470,588
Shares issuable upon conversion of preferred stock held in escrow		7,352,939
Shares issuable under common stock warrants		1,477,731
Shares issuable under common stock warrants held in escrow		7,352,939
Non-vested portion of restricted stock grants		545,361
Shares issuable under stock options		375,675
Shares issuable under stock options subject to option plan approval		366,468